Choice Hotels International, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CHH research report →
Range $93 – $130
Price Chart
About the company
Choice Hotels International, Inc. , also known as Choice Hotels, operates as a prominent global hotel franchisor, conducting its extensive business through its various subsidiary entities. The company's activities are primarily divided into two main segments: Hotel Franchising and Corporate & Other.
- CEO
- Dominic Dragisich
- IPO
- 1996
- Employees
- 1,754
- HQ
- North Bethesda, MD, US
Get TickerSpark's AI analysis on CHH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $5.35B
- P/E
- 26.54
- Fwd P/E
- 17.00
- PEG
- -0.59
- P/S
- 3.28
- P/B
- 41.23
- EV/EBITDA
- 15.66
- Div Yield
- 0.96%
- Gross Margin
- 38.36%
- Op Margin
- 23.00%
- Net Margin
- 12.64%
- ROE
- 139.04%
- ROIC
- 10.73%
Latest fiscal year · YoY change
- Revenue
- $1.60B+0.8%
- Gross Profit
- $653.86M-12.1%
- Op Income
- $453.10M
- Net Income
- $369.95M+23.5%
- EPS
- $7.97+27.3%
- OCF Growth
- -15.3%
- FCF Growth
- -28.2%
- Beta
- 0.67
- RSI (14)
- 53
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Choice Hotels said Q3 showed improving U.S. rooms growth and RevPAR momentum, while higher expenses limited near-term earnings leverage even as the company raised full-year guidance.· November 2, 2026
- U.S. net rooms growth improved for a third straight quarter and was flat year over year in Q3; management expects about 1% U.S. net rooms growth by year-end.
- U.S. RevPAR rose 3.8% year over year in Q3, with October up about 7%; the company raised full-year U.S. and global RevPAR guidance.
- Adjusted EBITDA increased to about $193 million, adjusted EPS rose about 11% to $2.33, and revenue excluding reimbursables was $285 million.
- Management said franchisee retention, conversions, and development activity are improving, while commercial tools like RAIZ, EasyBid, and Choice Privileges are supporting performance.
- Capital outlays are falling as development winds down, and the company completed the $130 million Harvest Hosts acquisition while continuing hotel asset sales.
Third-quarter adjusted EBITDA was approximately $193 million, up 1% year over year. Revenue excluding reimbursable revenue from franchised and managed properties increased 3% year over year to $285 million, and adjusted diluted EPS increased approximately 11% year over year to $2.33. Excluding liquidated damages revenue, adjusted EBITDA and revenue each grew 5%. Global RevPAR increased 3.9% year over year in Q3; U.S. RevPAR increased 3.8%; and international RevPAR increased 3.7% on a currency-neutral basis. For full year 2026, management raised adjusted EBITDA guidance to $641 million to $651 million and narrowed adjusted diluted EPS guidance to $6.92 to $7.07. It now expects full-year U.S. RevPAR growth and global RevPAR growth of 1.5% to 2.5%, U.S. average royalty rate expansion of about 9 basis points, global net rooms growth of about 1.5%, and U.S. net rooms growth of about 1% by year-end. Excluding Harvest Hosts, full-year adjusted SG&A is now expected to increase 9% year over year, and repurchases are expected to be about $200 million for the year.
Dominic Dragasich framed the quarter as evidence that Choice is getting back to its core franchise model: improving U.S. rooms growth, strengthening franchisee economics, and moving to a more capital-efficient structure. He said the company is seeing better retention, stronger conversion activity, and improving relative RevPAR, and he sounded confident that the Q4 step-up in openings and the commercial initiatives now rolling out can carry into 2027. His tone was upbeat and execution-focused, with repeated emphasis on discipline, accountability, and returning to asset-light franchising.
Scott Oaksmith highlighted the quarter’s financial bridge: adjusted EBITDA of about $193 million, $285 million of revenue excluding reimbursables, and adjusted EPS of $2.33. He said higher SG&A, including strategic investments and higher A/R reserves, partly offset stronger royalties and revenue growth, while a $24 million termination charge hit reported net income but was excluded from adjusted results. On capital allocation, he noted year-to-date hotel development outlays of $36 million, expected full-year development outlays of about $20 million versus $103 million in 2025, total liquidity of $928 million, and net leverage of 3.2x adjusted EBITDA. He also said the company completed a $500 million term loan refinancing, sold two owned hotels for about $34 million in proceeds, and expects more disposition activity and lower capital requirements in 2027.
Analysts pressed management on the sustainability of the U.S. rooms-growth acceleration, the pace and timing of commercial initiative benefits, owned-hotel sale inventory, free cash flow conversion, and the impact of key money and retained deal economics. Management said the U.S. rooms outlook is supported by improved retention, stronger openings, and a conversion-led pipeline, and that the commercial tools are still early but should increasingly help rate performance, with RAIZ expected to matter more next year. On asset sales, Scott said the pool includes 17 owned hotels after recent sales, with roughly $455 million of owned-asset capital available for sale coming into the quarter, while management said the $24 million contract termination was a legacy deal that no longer fit its asset-light strategy. On cash flow, they said lower development spending and a narrowing reimbursable deficit should help bring free cash flow conversion back toward the historical 55% to 60% range over the next couple of years.
The call showed tangible momentum in Choice’s core metrics: U.S. RevPAR is improving, rooms growth is inflecting, and franchisee pipeline/agreements are rising. Management also pointed to multiple levers for 2027—higher openings, better retention, lower development spending, and easing SG&A growth—that could expand free cash flow and earnings leverage.
Near-term earnings are still being held back by higher SG&A, elevated marketing and reservation spending, and a higher interest expense profile, which narrowed EPS guidance despite stronger EBITDA. Management also said the commercial investments are still early, the AI traffic contribution is tiny today, and some of the expected benefit from rate tools like RAIZ may not show up meaningfully until 2027.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 54.7%
- Shares Outstanding
- 44.51M
- Float Shares
- 24.36M
of shares held by institutions
345 13F filers
Buy/sell ratio 3.33. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for CHH, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Bamco Inc | 9.33M | ▲ 1.64M |
| Morgan Stanley | 2.60M | ▼ 289.17K |
| Vanguard Group Inc | 2.33M | ▲ 27.03K |
| Blackrock, Inc. | 2.31M | ▲ 43.76K |
| Vanguard Portfolio Management LLC | 1.30M | ▲ 201.00K |
| Vanguard Capital Management LLC | 1.30M | ▲ 223.17K |
| Balyasny Asset Management L.P. | 1.09M | ▼ 78.20K |
| Voss Capital, LP | 910.00K | ▼ 57.50K |
| Boston Trust Walden Corp | 854.47K | ▼ 44.46K |
| State Street Corp | 761.66K | ▲ 15.10K |
| Citadel Advisors LLC | 742.11K | ▲ 368.58K |
| Dimensional Fund Advisors LP | 724.79K | ▲ 115.46K |
Held by 434 ETFs
Biggest fund positions in CHH by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 18, 26 | Oaksmith Scott E | sell | 3,547 |
| Nov 4, 26 | Oaksmith Scott E | sell | 1,998 |
| Nov 4, 26 | Oaksmith Scott E | sell | 2 |
| Oct 20, 26 | Dragisich Dominic | sell | 1,227 |
| Oct 15, 26 | VIEIRA DONNA F | other | 3.5 |
| Oct 15, 26 | Ramirez Sanchez Raul | other | 9.32 |
| Oct 15, 26 | Smith Gordon | other | 23.24 |
| Oct 15, 26 | JEWS WILLIAM L | other | 17.17 |
| Oct 15, 26 | Landsman Liza | other | 21.59 |
| Oct 15, 26 | Maureen Sullivan | other | 29.98 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CHH coverage
Recent articles, reports, and earnings notes.
Want a deeper read on CHH?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
